Engineered exosomes boost the HCV NS3-specific CD8+ T lymphocyte immunity in humans-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Engineered exosomes boost the HCV NS3-specific CD8+ T lymphocyte immunity in humans

Published:2016 Issue: Volume:5 Page:105-110
ISSN:1879-4378
Container-title:Trials in Vaccinology
language:en
Short-container-title:Trials in Vaccinology

Author:

Anticoli Simona,Falcone Emiliana,Ruggieri Anna,Federico Maurizio

Funder

Ministry of Health, Italy

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Immunology,Microbiology

Reference19 articles.

1. An update on the treatment of genotype-1 chronic hepatitis C infection: lessons from recent clinical trials;Wendt;Ther. Adv. Infect. Dis.,2013

2. Current progress in development of hepatitis C virus vaccines;Liang;Nat. Med.,2013

3. Analysis of a successful immune response against hepatitis C virus;Cooper;Immunity,1999

4. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers;He;Proc. Natl. Acad. Sci. U.S.A.,1999

5. Immunity to hepatitis C virus: stunned but not defeated;Klenerman;Microbes Infect.,2002

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosome-Mediated Antigen Delivery: Unveiling Novel Strategies in Viral Infection Control and Vaccine Design;Vaccines;2024-03-07

2. The role of miRNAs in liver diseases: Potential therapeutic and clinical applications;Pathology - Research and Practice;2023-03

3. The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology;Clinical and Molecular Hepatology;2022-10-01

4. The C-Terminal Domain of Nefmut Is Dispensable for the CD8+ T Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles;Vaccines;2021-04-12

5. Emerging role and therapeutic application of exosome in hepatitis virus infection and associated diseases;Journal of Gastroenterology;2021-03-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3